Related Experiment Video
Updated: Feb 13, 2026

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
7.4K
Robotic Sleeve Gastrectomy for Morbid Obesity
1Department of General Surgery, Koru Hospital, Ankara, Turkey.
Summary
Robotic sleeve gastrectomy using a vessel sealer and triple stapler is safe and effective for weight loss in obese patients, with minimal complications. This approach facilitates the procedure for enhanced patient outcomes.
Area of Science:
- Bariatric Surgery
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Obesity surgery presents challenges requiring advanced techniques.
- Robotic surgery offers potential benefits in complex procedures like sleeve gastrectomy.
- Evaluating new instruments like vessel sealers and triple staplers is crucial for safety and efficacy.
Purpose of the Study:
- To assess the safety and efficacy of vessel sealer and triple stapler in robotic sleeve gastrectomy.
- To determine weight loss and complication rates associated with this surgical approach.
- To exemplify the use of these instruments in robotic bariatric surgery.
Main Methods:
- An observational case series of twenty robotic sleeve gastrectomies was conducted.
- Data collected included demographics, body mass index, comorbidities, surgical times, and outcomes.
- Specific focus on complications, stapler usage, and weight loss at three months.
Main Results:
- No conversions, strictures, leakage, or mortality were observed.
- One instance of postoperative bleeding at the trocar site occurred.
- Mean excess body weight loss (EWL%) at three months was 24.91 ±2.84 kg, with an average of 6.27 staplers used.
Conclusions:
- Robotic sleeve gastrectomy with vessel sealer and triple stapler is a safe and effective initial approach for obese patients.
- These instruments facilitate the procedure, demonstrating efficacy in achieving weight loss.
- The study highlights the safety of robotic surgery in bariatric procedures during early experience.
Related Concept Videos
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
296
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
296
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
197
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
197

